BioLife Solutions, Inc.BLFSNASDAQ
LOADING
|||
Revenue Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
10.41%
↓ 62% below average
Average (39q)
27.05%
Historical baseline
Range
High:799.21%
Low:-111.20%
CAGR
-0.3%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 10.41% |
| Q2 2025 | 6.18% |
| Q1 2025 | 799.21% |
| Q4 2024 | -111.20% |
| Q3 2024 | 55.06% |
| Q2 2024 | 6.95% |
| Q1 2024 | 6.00% |
| Q4 2023 | -26.23% |
| Q3 2023 | -40.33% |
| Q2 2023 | 4.79% |
| Q1 2023 | -14.81% |
| Q4 2022 | 8.62% |
| Q3 2022 | 0.53% |
| Q2 2022 | 11.91% |
| Q1 2022 | -2.91% |
| Q4 2021 | 10.37% |
| Q3 2021 | 8.32% |
| Q2 2021 | 85.22% |
| Q1 2021 | 14.40% |
| Q4 2020 | 30.56% |
| Q3 2020 | 13.70% |
| Q2 2020 | -18.43% |
| Q1 2020 | 46.62% |
| Q4 2019 | 25.61% |
| Q3 2019 | -1.45% |
| Q2 2019 | 16.14% |
| Q1 2019 | 5.76% |
| Q4 2018 | 3.08% |
| Q3 2018 | 2.23% |
| Q2 2018 | 35.73% |
| Q1 2018 | 21.73% |
| Q4 2017 | 5.76% |
| Q3 2017 | 15.86% |
| Q2 2017 | 8.10% |
| Q1 2017 | 5.16% |
| Q4 2016 | 5.38% |
| Q3 2016 | 7.30% |
| Q2 2016 | 7.45% |
| Q1 2016 | 1.79% |
| Q4 2015 | 11.49% |